| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169562 Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169554 Polypeptides of Leishmania Major and Polynucleotides Encoding Same and Vaccinal, Therapeutical and Diagnostic Applications Thereof |
| 07/02/2009 | US20090169553 Novel Protein Fusion/Tag Technology |
| 07/02/2009 | US20090169552 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5 |
| 07/02/2009 | US20090169548 Binding molecules |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169536 Polypeptide Having Phytase Activity and Nucleotide Sequence Encoding the Same |
| 07/02/2009 | US20090169535 Treatment of epilepsy by expressing st3gal-iii |
| 07/02/2009 | US20090169534 Variant Forms of Urate Oxidase and Use Thereof |
| 07/02/2009 | US20090169529 Compositions and methods for immunostimulatory rna oligonucleotides |
| 07/02/2009 | US20090169526 Bmp-6 estrogen responsive element and methods of use thereof |
| 07/02/2009 | US20090169517 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules |
| 07/02/2009 | US20090169516 Method of constructing gene transport support |
| 07/02/2009 | US20090169514 Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy |
| 07/02/2009 | US20090169509 O-linked glycosylation of peptides |
| 07/02/2009 | US20090169505 Novel vaccines against multiple subtypes of influenza virus |
| 07/02/2009 | US20090169479 Compounds Comprising Short Aminoalcohol Chains and Metal Complexes for Medical Imgaing |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | US20090169472 Methods and compositions for treating immune disorders |
| 07/02/2009 | US20090166196 Use of microfluidic systems in the electrochemical detection of target analytes |
| 07/02/2009 | CA2710600A1 Recombinant rsv antigens |
| 07/02/2009 | CA2710595A1 Polysaccharide synthases (h) |
| 07/02/2009 | CA2710262A1 An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts |
| 07/02/2009 | CA2710145A1 Screening |
| 07/02/2009 | CA2710140A1 Polypeptide libraries with a predetermined scaffold |
| 07/02/2009 | CA2709894A1 Mammalian expression vector |
| 07/02/2009 | CA2709675A1 Glycosyltransferases, polynucleotides encoding these and methods of use |
| 07/02/2009 | CA2709645A1 Sm-protein based secretion engineering |
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | CA2709632A1 Elimination of contaminants associated with nucleic acid amplification |
| 07/02/2009 | CA2709503A1 Organic compounds |
| 07/02/2009 | CA2709500A1 Type iii secretion system component protein pa1698 of pseudomonas aeruginosa |
| 07/02/2009 | CA2708740A1 Hepatitis c virus antibodies |
| 07/02/2009 | CA2708506A1 Plants having enhanced yield-related traits and a method for making the same |
| 07/02/2009 | CA2708499A1 Plants with increased yield (ko nue) |
| 07/02/2009 | CA2708074A1 Non-aggregating human vh domains |
| 07/01/2009 | EP2075582A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/01/2009 | EP2075346A2 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/01/2009 | EP2075341A1 Method for study, determination or evaluation by gene expression analysis |
| 07/01/2009 | EP2075340A2 Gene modulation by RB2/p 130 expression |
| 07/01/2009 | EP2075338A2 Improved saccharification of cellulose by cloning and amplification of the ß -glucosidase gene of trichoderma reesei |
| 07/01/2009 | EP2075336A1 Purification of recombinant proteins fused to multiple epitopes |
| 07/01/2009 | EP2075335A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 07/01/2009 | EP2075333A1 Positive controls for expression modulating experiments |
| 07/01/2009 | EP2075332A1 Cytokine production regulator gene and use thereof |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075257A1 Preparation of antibody using mrl/lpr mouse |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075254A1 Therapeutic use of a growth factor, NsG33 |
| 07/01/2009 | EP2075253A1 Compositions and methds for the diagnosis and treatment of disorders involving angiogensis |
| 07/01/2009 | EP2074229A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 07/01/2009 | EP2074220A2 Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko |
| 07/01/2009 | EP2074219A1 Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants |
| 07/01/2009 | EP2074218A1 Methods and means for producing starch having at least one altered characteristic |
| 07/01/2009 | EP2074217A1 Expression of tgf-beta in plastids |
| 07/01/2009 | EP2074216A1 Process for the production of recombinant proteins using carnivorous plants. |
| 07/01/2009 | EP2074215A2 Improved alpha factor signal peptide for producing a polypeptide |
| 07/01/2009 | EP2074214A2 Production of sterols in oleaginous yeast and fungi |
| 07/01/2009 | EP2074213A2 Real time monitoring of microbial enzymatic pathways |
| 07/01/2009 | EP2074212A1 Thermus eggertssonii dna polymerases |
| 07/01/2009 | EP2074211A2 Polymerase |
| 07/01/2009 | EP2074210A2 Integration of sample storage and sample management for life science |
| 07/01/2009 | EP2074149A2 Compositions and methods relating to glucagon receptor antibodies |
| 07/01/2009 | EP2074147A1 Antibodies against ccr5 and uses thereof |
| 07/01/2009 | EP2074146A2 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 07/01/2009 | EP2074144A2 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/01/2009 | EP2074141A1 Protease resistant insulin analogues |
| 07/01/2009 | EP2074140A2 Fibrillation-resistant insulin and insulin analogues |
| 07/01/2009 | EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 07/01/2009 | EP2073849A2 Methods and compositions for gene therapy |
| 07/01/2009 | EP2073818A2 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 07/01/2009 | EP2006679A9 Biochip substrate and biochip |
| 07/01/2009 | EP1969123A4 Novel enzymes |
| 07/01/2009 | EP1937818A4 Gene cry7bal encoding an insecticidal crystal protein of bacillus thuringiensis |
| 07/01/2009 | EP1882392A4 Genes and uses for plant improvement |
| 07/01/2009 | EP1831252B1 Glp-1 analog fusion protein formulations |
| 07/01/2009 | EP1774005B1 Method for enhancing gene expression in plants |
| 07/01/2009 | EP1680506B1 Meg1 endosperm-specific promoters and genes |
| 07/01/2009 | EP1677665A4 Determination of ions using ion-sensitive enzymes |
| 07/01/2009 | EP1673106B1 Optimized expression of hpv 45 l1 in yeast |
| 07/01/2009 | EP1648224B1 Rat model of diabetic nephropathy |
| 07/01/2009 | EP1599584B1 Modified nitrilases and their use in methods for the production of carboxylic acids |
| 07/01/2009 | EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/01/2009 | EP1552018B1 Methods and compositions relating to gene silencing |
| 07/01/2009 | EP1551222B1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1458869B1 Alleles of the glucokinase gene coryneform bacteria |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1356040B1 14189, a human kinase and uses thereof |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1334184B1 A combined electroporation and microinjection method for the penetration of lipid bilayer membranes |
| 07/01/2009 | EP1330553B1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 07/01/2009 | EP1315417B1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1263939B1 18477, a human protein kinase and uses therefor |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |